The phenotype and treatment of SCN2A-related developmental and epileptic encephalopathy

Medicine and Dentistry

• Patient 100%
• Sodium Channel Blocker 50%
• Brain Disease 33%
• Therapeutic Procedure 33%
• Childhood 33%
• Partial Seizure 25%
• Epilepsy 16%
• Pervasive Developmental Disorder 16%
• Ketogenic Diet 16%
• Epileptic Seizure 16%
• Phenotype 8%
• Anticonvulsant 8%
• Disease Course 8%
• Neonates 8%
• Drug Megadose 8%
• Infancy 8%
• Infantile Spasm 8%
• Missense Mutation 8%
• Drug Resistant Epilepsy 8%
• Steroid Treatment 8%
• Epilepsy Syndromes 8%
• Ohtahara Syndrome 8%
• Inpatient 8%
• Observation 8%
• Infant 8%

Neuroscience

• Epilepsy 33%
• Encephalopathy 33%
• Seizure 25%
• Focal Epilepsy 16%
• Ketogenic Diet 16%
• Phenotype 8%
• Missense Mutation 8%
• Steroids 8%
• Anticonvulsant 8%